Parallel functional and immunological detection of human multidrug resistance proteins, P-glycoprotein and MRP1

被引:0
|
作者
Holló, Z [1 ]
Homolya, L [1 ]
Hegedûs, T [1 ]
Müller, M [1 ]
Szakács, G [1 ]
Jakab, K [1 ]
Antal, F [1 ]
Sarkadi, B [1 ]
机构
[1] Hungarian Acad Sci, Natl Inst Haematol & Immunol, Membrane Res Grp, H-1113 Budapest, Hungary
关键词
multiple drug resistance; P-glycoprotein; multidrug resistance-associated protein; ABC transporters; fluorometry; digital imaging; neoplasms; immunofluorescence; calcein;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The proper assessment of the expression and drug extrusion activity of multidrug resistance proteins in various tumor cells is a challenging clinical laboratory problem. Recently, we have introduced a fluorescent dye (calcein) accumulation assay for the estimation of the functional expression of both P-glycoprotein (MDR1) and the multidrug resistance-associated protein (MRP1). Since both MDR1 and MRP1 decrease the intracellular accumulation of the fluorescent free calcein, by applying appropriate inhibitors of MDR1 and MRP1, the transport activity of these proteins could be quantitatively and selectively estimated in fluorometry or flow-cytometry assays. In the present work single-cell fluorescence digital imaging has been applied to characterize the kinetics and inhibitor-sensitivity of calcein accumulation in a mixture of HL60 MRP1 and NIH 3T3 MDR1 cells. Subsequent immunofluorescence labeling was performed by the anti-MDR1 monoclonal antibody (mAb) UIC2 in the same cell population. We report that the double labeling approach, based on the single cell calcein accumulation assay and an immunofluorescence detection, provides good sensitivity and selectivity for the simultaneous functional and immunological detection of cellular MDR1 and MRP1.
引用
收藏
页码:2981 / 2987
页数:7
相关论文
共 50 条
  • [31] P-glycoprotein and multidrug resistance
    Johnston, JMN
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (20): : 1336 - 1336
  • [32] The Antiepileptic Drug Topiramate is a Substrate for Human P-glycoprotein but Not Multidrug Resistance Proteins
    Luna-Tortos, Carlos
    Rambeck, Bernhard
    Juergens, Uwe H.
    Loescher, Wolfgang
    PHARMACEUTICAL RESEARCH, 2009, 26 (11) : 2464 - 2470
  • [33] P-GLYCOPROTEIN AND MULTIDRUG RESISTANCE
    SKUBITZ, KM
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1990, 93 (01) : 156 - 157
  • [34] THE MULTIDRUG RESISTANCE P-GLYCOPROTEIN
    HIGGINS, CF
    PEDIATRIC PULMONOLOGY, 1992, : 100 - 100
  • [35] Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3)
    Lespine, A
    Dupuy, J
    Orlowski, S
    Nagy, T
    Glavinas, H
    Krajcsi, P
    Alvinerie, M
    CHEMICO-BIOLOGICAL INTERACTIONS, 2006, 159 (03) : 169 - 179
  • [36] P-GLYCOPROTEIN AND MULTIDRUG RESISTANCE
    LING, V
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 11 - 11
  • [37] P-glycoprotein and multidrug resistance
    Gottesman, MM
    Pastan, I
    Ambudkar, SV
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 1996, 6 (05) : 610 - 617
  • [38] Structural and Functional Properties of Human Multidrug Resistance Protein 1 (MRP1/ABCC1)
    He, S. -M.
    Li, R.
    Kanwar, J. R.
    Zhou, S. -F.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (03) : 439 - 481
  • [39] Molecular dissection of the human multidrug resistance P-glycoprotein
    Loo, TW
    Clarke, DM
    BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1999, 77 (01): : 11 - 23
  • [40] MULTIDRUG RESISTANCE AND P-GLYCOPROTEIN EXPRESSION IN HUMAN CANCER
    MA, DDF
    BELL, DR
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1989, 19 (06): : 736 - 743